Method of preparing an osteogenic bone graft
View Patent ↗The present disclosure is directed to a method of preparing an osteogenic bone graft. The method includes introducing an anticoagulant compound into a volume of cellular material including a mononuclear cell population from the intramedullary canal of a long bone; collecting an effluent including the volume of cellular material containing the anticoagulant compound at a collection point; separating a concentrated cell fraction from the effluent, the concentrated cell fraction including the mononuclear cell population and the anticoagulant compound; and preparing an osteogenic bone graft from the concentrated cell fraction.
1. A method of collecting a mononuclear cell population for use in preparing an osteogenic bone graft comprising:
harvesting a volume of cellular material from the intramedullary canal of a long bone to which access is gained using a surgical reamer, wherein the volume of cellular material includes the mononuclear cell population, and wherein the harvested volume of cellular material is contained within an effluent;
introducing an anticoagulant compound into the effluent during the step of harvesting, wherein the anticoagulant compound is metered into the effluent continuously and in proportion to a volume of effluent being harvested;
filtering the effluent in order to remove a course residue therefrom, wherein the filtering is downstream of the introduction of the anticoagulant; and,
collecting the filtered effluent including the mononuclear cell population and the anticoagulant compound at a collection point.
2. The method of claim 1 , wherein the anticoagulant compound is introduced at a ratio in a range of about 2 parts to about 10 parts, by weight, effluent to anticoagulant compound.
3. The method of claim 1 , wherein the proportionate introduction of the anticoagulant compound is tortuous mixing of the effluent and the anticoagulant.
4. The method of claim 1 , further comprising a step of retaining an amount of autologous bone graft from the coarse residue.
5. The method of claim 1 , wherein collecting the effluent includes first collecting at an intermediate collection point, and subsequently collecting at a processing collection point.
6. The method of claim 1 , wherein all of the steps are performed intraoperatively in a single procedure.
7. The method of claim 1 , wherein the step of harvesting includes irrigating the intramedullary canal with a surgical reaming device including an irrigation stream.
8. The method of claim 7 , wherein the anticoagulant compound is continuously introduced into the effluent through the irrigation stream.
9. The method of claim 1 , wherein access to the intermedullary canal of the long bone is obtained by a step of forming an opening in the long bone using the surgical reamer and advancing the surgical reamer through the bone into the intermedullary canal.
10. The method of claim 9 further comprising placing an implant component in the opening of the long bone formed by the surgical reamer.
11. The method of claim 1 , wherein at least about 88% of cells within the mononuclear cell population in the collected effluent represent viable cells.
12. The method of claim 1 , wherein at least about 92% of cells within the mononuclear cell population in the collected effluent represent viable cells.
13. The method of claim 1 , wherein the coarse residue includes bone particles, agglomerations of fat, clots, or any combination thereof.
14. The method of claim 1 , further comprising retaining the coarse residue that is removed by filtering the effluent.
15. The method of claim 14 , wherein autologous bone graft material is retained from the coarse residue.
16. The method of claim 1 , wherein the filtering includes the use of a filter having an average pore size of about 500 microns.